Global and United States Carbamazepine Market Report & Forecast 2023-2028

Report ID: 1808375 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Carbamazepine Product Introduction
    1.2 Global Carbamazepine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Carbamazepine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Carbamazepine Sales in Volume for the Year 2017-2028
    1.3 United States Carbamazepine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Carbamazepine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Carbamazepine Sales in Volume for the Year 2017-2028
    1.4 Carbamazepine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Carbamazepine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Carbamazepine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Carbamazepine Market Dynamics
        1.5.1 Carbamazepine Industry Trends
        1.5.2 Carbamazepine Market Drivers
        1.5.3 Carbamazepine Market Challenges
        1.5.4 Carbamazepine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Carbamazepine Market Segment by Type
        2.1.1 Capsule
        2.1.2 Tablet
    2.2 Global Carbamazepine Market Size by Type
        2.2.1 Global Carbamazepine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Carbamazepine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Carbamazepine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Carbamazepine Market Size by Type
        2.3.1 United States Carbamazepine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Carbamazepine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Carbamazepine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Carbamazepine Market Segment by Application
        3.1.1 Seizures
        3.1.2 Nerve Pain
        3.1.3 Others
    3.2 Global Carbamazepine Market Size by Application
        3.2.1 Global Carbamazepine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Carbamazepine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Carbamazepine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Carbamazepine Market Size by Application
        3.3.1 United States Carbamazepine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Carbamazepine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Carbamazepine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Carbamazepine Competitor Landscape by Company
    4.1 Global Carbamazepine Market Size by Company
        4.1.1 Top Global Carbamazepine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Carbamazepine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Carbamazepine Sales by Manufacturer (2017-2022)
        4.1.4 Global Carbamazepine Price by Manufacturer (2017-2022)
    4.2 Global Carbamazepine Concentration Ratio (CR)
        4.2.1 Carbamazepine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Carbamazepine in 2021
        4.2.3 Global Carbamazepine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Carbamazepine Manufacturing Base Distribution, Product Type
        4.3.1 Global Carbamazepine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Carbamazepine Product Type
        4.3.3 Date of International Manufacturers Enter into Carbamazepine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Carbamazepine Market Size by Company
        4.5.1 Top Carbamazepine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Carbamazepine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Carbamazepine Sales by Players (2020, 2021 & 2022)
5 Global Carbamazepine Market Size by Region
    5.1 Global Carbamazepine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Carbamazepine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Carbamazepine Sales in Volume by Region: 2017-2022
        5.2.2 Global Carbamazepine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Carbamazepine Market Size in Value by Region (2017-2028)
        5.3.1 Global Carbamazepine Sales in Value by Region: 2017-2022
        5.3.2 Global Carbamazepine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Carbamazepine Market Size YoY Growth 2017-2028
        6.1.2 North America Carbamazepine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Carbamazepine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Carbamazepine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Carbamazepine Market Size YoY Growth 2017-2028
        6.3.2 Europe Carbamazepine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Carbamazepine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Carbamazepine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Carbamazepine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Carbamazepine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Corporation Information
        7.1.2 Novartis Description and Business Overview
        7.1.3 Novartis Carbamazepine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Novartis Carbamazepine Products Offered
        7.1.5 Novartis Recent Development
    7.2 Apotex Corporation
        7.2.1 Apotex Corporation Corporation Information
        7.2.2 Apotex Corporation Description and Business Overview
        7.2.3 Apotex Corporation Carbamazepine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Apotex Corporation Carbamazepine Products Offered
        7.2.5 Apotex Corporation Recent Development
    7.3 Teva
        7.3.1 Teva Corporation Information
        7.3.2 Teva Description and Business Overview
        7.3.3 Teva Carbamazepine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Teva Carbamazepine Products Offered
        7.3.5 Teva Recent Development
    7.4 Biomed Pharma
        7.4.1 Biomed Pharma Corporation Information
        7.4.2 Biomed Pharma Description and Business Overview
        7.4.3 Biomed Pharma Carbamazepine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Biomed Pharma Carbamazepine Products Offered
        7.4.5 Biomed Pharma Recent Development
    7.5 Nucare Pharmaceuticals
        7.5.1 Nucare Pharmaceuticals Corporation Information
        7.5.2 Nucare Pharmaceuticals Description and Business Overview
        7.5.3 Nucare Pharmaceuticals Carbamazepine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Nucare Pharmaceuticals Carbamazepine Products Offered
        7.5.5 Nucare Pharmaceuticals Recent Development
    7.6 Taro Pharmaceuticals
        7.6.1 Taro Pharmaceuticals Corporation Information
        7.6.2 Taro Pharmaceuticals Description and Business Overview
        7.6.3 Taro Pharmaceuticals Carbamazepine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Taro Pharmaceuticals Carbamazepine Products Offered
        7.6.5 Taro Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Carbamazepine Industry Chain Analysis
    8.2 Carbamazepine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Carbamazepine Distributors
    8.3 Carbamazepine Production Mode & Process
    8.4 Carbamazepine Sales and Marketing
        8.4.1 Carbamazepine Sales Channels
        8.4.2 Carbamazepine Distributors
    8.5 Carbamazepine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Carbamazepine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Carbamazepine Market Trends
    Table 3. Carbamazepine Market Drivers
    Table 4. Carbamazepine Market Challenges
    Table 5. Carbamazepine Market Restraints
    Table 6. Global Carbamazepine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Carbamazepine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Carbamazepine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Carbamazepine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Carbamazepine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Carbamazepine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Carbamazepine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Carbamazepine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Carbamazepine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Carbamazepine Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Carbamazepine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Carbamazepine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbamazepine as of 2021)
    Table 18. Top Players of Carbamazepine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Carbamazepine Product Type
    Table 20. Date of International Manufacturers Enter into Carbamazepine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Carbamazepine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Carbamazepine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Carbamazepine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Carbamazepine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Carbamazepine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Carbamazepine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Carbamazepine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Carbamazepine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Carbamazepine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Carbamazepine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Carbamazepine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Carbamazepine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Carbamazepine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Carbamazepine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Carbamazepine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Carbamazepine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Carbamazepine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Carbamazepine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Carbamazepine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Carbamazepine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novartis Corporation Information
    Table 43. Novartis Description and Business Overview
    Table 44. Novartis Carbamazepine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Novartis Carbamazepine Product
    Table 46. Novartis Recent Development
    Table 47. Apotex Corporation Corporation Information
    Table 48. Apotex Corporation Description and Business Overview
    Table 49. Apotex Corporation Carbamazepine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Apotex Corporation Product
    Table 51. Apotex Corporation Recent Development
    Table 52. Teva Corporation Information
    Table 53. Teva Description and Business Overview
    Table 54. Teva Carbamazepine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Teva Product
    Table 56. Teva Recent Development
    Table 57. Biomed Pharma Corporation Information
    Table 58. Biomed Pharma Description and Business Overview
    Table 59. Biomed Pharma Carbamazepine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Biomed Pharma Product
    Table 61. Biomed Pharma Recent Development
    Table 62. Nucare Pharmaceuticals Corporation Information
    Table 63. Nucare Pharmaceuticals Description and Business Overview
    Table 64. Nucare Pharmaceuticals Carbamazepine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Nucare Pharmaceuticals Product
    Table 66. Nucare Pharmaceuticals Recent Development
    Table 67. Taro Pharmaceuticals Corporation Information
    Table 68. Taro Pharmaceuticals Description and Business Overview
    Table 69. Taro Pharmaceuticals Carbamazepine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Taro Pharmaceuticals Product
    Table 71. Taro Pharmaceuticals Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Carbamazepine Customers List
    Table 75. Carbamazepine Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Carbamazepine Product Picture
    Figure 2. Global Carbamazepine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Carbamazepine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Carbamazepine Sales 2017-2028 (K Units)
    Figure 5. United States Carbamazepine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Carbamazepine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Carbamazepine Sales 2017-2028 (K Units)
    Figure 8. United States Carbamazepine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Carbamazepine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Carbamazepine Report Years Considered
    Figure 11. Product Picture of Capsule
    Figure 12. Product Picture of Tablet
    Figure 13. Global Carbamazepine Market Share by Type in 2022 & 2028
    Figure 14. Global Carbamazepine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Carbamazepine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Carbamazepine Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Carbamazepine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Carbamazepine Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Carbamazepine Market Share by Type in 2022 & 2028
    Figure 20. United States Carbamazepine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Carbamazepine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Carbamazepine Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Carbamazepine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Carbamazepine Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Seizures
    Figure 26. Product Picture of Nerve Pain
    Figure 27. Product Picture of Others
    Figure 28. Global Carbamazepine Market Share by Application in 2022 & 2028
    Figure 29. Global Carbamazepine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Carbamazepine Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Carbamazepine Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Carbamazepine Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Carbamazepine Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Carbamazepine Market Share by Application in 2022 & 2028
    Figure 35. United States Carbamazepine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Carbamazepine Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Carbamazepine Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Carbamazepine Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Carbamazepine Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Carbamazepine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Carbamazepine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Carbamazepine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Carbamazepine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Carbamazepine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Carbamazepine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Carbamazepine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Carbamazepine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Carbamazepine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Carbamazepine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Carbamazepine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Carbamazepine Value Chain
    Figure 73. Carbamazepine Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Apotex Corporation
Teva
Biomed Pharma
Nucare Pharmaceuticals
Taro Pharmaceuticals
Frequently Asked Questions
Carbamazepine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Carbamazepine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Carbamazepine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Painkillers

Painkillers market is segmented by region (country), players, by Type and by Application. Players ... Read More